RUNX3 Controls a Metastatic Switch in Pancreatic Ductal Adenocarcinoma-Reference-Cited by-同舟云学术

RUNX3 Controls a Metastatic Switch in Pancreatic Ductal Adenocarcinoma

Published:2015-06 Issue:6 Volume:161 Page:1345-1360
ISSN:0092-8674
Container-title:Cell
language:en
Short-container-title:Cell

Author:

Whittle Martin C.,Izeradjene Kamel,Rani P. Geetha,Feng Libing,Carlson Markus A.,DelGiorno Kathleen E.,Wood Laura D.,Goggins Michael,Hruban Ralph H.,Chang Amy E.,Calses Philamer,Thorsen Shelley M.,Hingorani Sunil R.

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference41 articles.

1. Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma;Aguirre;Genes Dev.,2003

2. DNA content and other factors associated with ten-year survival after resection of pancreatic carcinoma;Allison;J. Surg. Oncol.,1998

3. Type I collagen promotes the malignant phenotype of pancreatic ductal adenocarcinoma;Armstrong;Clin. Cancer Res.,2004

4. Tumor suppressor activity of RUNX3;Bae;Oncogene,2004

5. Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse;Bardeesy;Proc. Natl. Acad. Sci. USA,2006

Cited by 176 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. miR-6855-5p Enhances Radioresistance and Promotes Migration of Pancreatic Cancer by Inducing Epithelial-Mesenchymal Transition via Suppressing FOXA1: Potential of Plasma Exosomal miR-6855-5p as an Indicator of Radiosensitivity in Patients with Pancreatic Cancer;Annals of Surgical Oncology;2024-09-13

2. Unveiling the Molecular Landscape of Pancreatic Ductal Adenocarcinoma: Insights into the Role of the COMPASS-like Complex;International Journal of Molecular Sciences;2024-05-07

3. Palmitoyl transferase ZDHHC20 promotes pancreatic cancer metastasis;Cell Reports;2024-05

4. Exploring the crosstalk of immune cells: The impact of dysregulated RUNX family genes in kidney renal clear cell carcinoma;Heliyon;2024-05

5. Modelling the micro- and macro- environment of pancreatic cancer: from patients to pre-clinical models and back;Disease Models & Mechanisms;2024-04-01